Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ivosidenib. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111349081B reveals a chiral protonic acid catalyzed Ugi reaction for Ivosidenib, eliminating chiral columns and toxic solvents for scalable manufacturing.